Progress is possible if urgent action is taken now, our new research reveals
Our new data says action needs to be taken to accelerate progress in ovarian cancer
Our new data says action needs to be taken to accelerate progress in ovarian cancer
A reminder why we fight: latest ovarian cancer data from NHS Digital reveals injustices that disproportionately affect those who die from ovarian cancer.
Research into screening for women with no symptoms of ovarian cancer concludes programme would not save lives.
Our gold-standard ovarian cancer research grants programme is open for 2021.
Innovative results published in Nature Genetics from our immunotherapy research project.
Target Ovarian Cancer is announcing a brand new award for research into a less common type of this disease.
Gamechanging drug olaparib is now available from beginning of treatment across the UK.
Today we've released new research on how much women know about breast cancer and ovarian cancer symptoms.
News from the European Society of Medical Oncology (ESMO) conference means more women could be able to access innovative treatments earlier.
Transformational funding from the Peter Sowerby Foundation will help us tackle the problem in a radically new way.
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer
Sign up